Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
09 juin 2023 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...
Global Surgical Procedures Market to Generate 372,837 thousand units by 2030, Outlines a New Report by Next Move Strategy Consulting
20 mai 2023 00h00 HE
|
Next Move Strategy Consulting
New York, May 20, 2023 (GLOBE NEWSWIRE) -- According to a new research report by Next Move Strategy Consulting, the Surgical Procedures Market size was 2,94,237 thousand units in 2022, and is...
New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
03 mai 2023 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced new research findings reinforcing the long-term...
Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
28 avr. 2023 17h42 HE
|
Predicine
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announced today that it will present two studies and introduce PredicineALERT™ Minimal Residual...
Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer
26 avr. 2023 15h44 HE
|
Blue Water Biotech, Inc.
CINCINNATI, April 26, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology company spanning multiple sectors, today announced the appointment of Jay...
Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones
20 avr. 2023 06h45 HE
|
Veru Inc.
MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related...
NextMed Provides Statement Regarding Unaffiliated Entity With Same Name in Wall Street Journal Article
29 mars 2023 06h00 HE
|
NextMed
TUCSON, Ariz., March 29, 2023 (GLOBE NEWSWIRE) -- Urology and lithotripsy services leader NextMed is issuing this statement in response to an article by the Wall Street Journal, published 4 March...
BetterCaths Coalition Assists Rep. Josh Turek in Designing Better Caths for Iowa Act to Remove Harmful Phthalate Chemical DEHP From Urological Catheters
26 févr. 2023 09h31 HE
|
BetterCaths Health Advocacy Coalition
DES MOINES, Iowa, Feb. 26, 2023 (GLOBE NEWSWIRE) -- In support of the disability community, Iowa State Representative Josh Turek (D-Iowa) has introduced the Better Caths for Iowa Act (H.F. 387) to...
Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium
23 févr. 2023 07h00 HE
|
Theralase Technologies Inc.
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success
16 févr. 2023 09h00 HE
|
Anderson Biotests, LLC
BEDFORD, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Anderson Biotests, LLC, in collaboration with the Bedford Research Foundation (www.bedfordresearch.org), recently published results of analyses of...